The Using Postoperative Ketamine and Exploring the Effect on Endometriosis Pain (UPKEEEP) Study
Status:
Not yet recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This is a randomized, single blinded, placebo-controlled trial to study the effectiveness of
a subanesthetic dose (0.6 mg/kg) of ketamine versus placebo (saline) on postoperative pain
and pain on adult female chronic pelvic pain patients undergoing robotic removal of
endometriosis. The objective of the study is to explore the effect of a sub anesthetic dose
of ketamine (0.6 mg/kg) vs. saline control on postoperative pain and recovery in chronic
pelvic pain patients who have undergone robotic removal of endometriosis.